A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit (PRIMAvera)
A Prospective, Multi-center, Non-comparative, 52-week Follow-up, Post-market Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit
Sponsor: Croma-Pharma GmbH
A observational or N/A phase clinical study on Midface Volume Deficit, this trial is completed. The trial is conducted by Croma-Pharma GmbH and has accumulated 8 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Jan 2025 — Present [monthly]
Completed
-
Sep 2024 — Jan 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2021 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Jan 2021 — Mar 2021 [monthly]
Unknown Status
▶ Show 3 earlier versions
-
Jun 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Sep 2018 — Jun 2020 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Croma-Pharma GmbH
- FGK Clinical Research GmbH
For direct contact, visit the study record on ClinicalTrials.gov .